Medical Device Information
Abbott Point of Care Inc. (APOC)

Abbott Point of Care Inc. (APOC)

admin222025-09-10 21:53:55

Company Overview

Abbott Point of Care Inc. (APOC), a subsidiary of Abbott Laboratories, was established in 2004 and specializes in handheld point-of-care (POC) diagnostics. Headquartered in Johnson City, New York, USA, APOC develops, manufactures, and markets critical diagnostic and data management products, including the market-leading i-STAT® System for rapid blood analysis at the bedside. The Ottawa facility produces cartridges for the i-STAT® System. APOC holds ISO 14001 certification and maintains an Environmental Management System (EMS) to support sustainability initiatives.

Core Business and Product Pipeline

APOC focuses on POC diagnostic products across infectious diseases, cardiometabolic conditions, toxicology, and informatics. Key products include:
       i-STAT® System: Handheld blood analyzer providing lab-quality results in minutes, widely used in emergency, critical care, and operating rooms. The i-STAT® Alinity™ system enhances flexibility and reliability.
       ID NOW™ Platform: Rapid molecular testing for infectious diseases, including influenza, RSV, streptococcus A, and COVID-19.
       BinaxNOW™ and Panbio™ Rapid Diagnostic Tests: Lateral flow assays for infectious diseases, cardiac markers, and drug abuse detection.
       Alere™ Toxicology Screen: Quick screening test for drugs of abuse, delivering reliable results in minutes.

Market Position and Key Products

APOC is a global leader in rapid POC diagnostics, known for speed, accuracy, and reliability. Its products enable timely treatment decisions, are easy to use at the bedside, and apply to diverse clinical settings such as hospitals, clinics, emergency departments, and critical care units. APOC's i-STAT® System and ID NOW™ platform are widely recognized and adopted by healthcare professionals worldwide.

Financial Performance

Abbott, APOC's parent company, reported $43.35 billion in revenue and $8.27 billion in net income in 2022. Its Diagnostics segment, which includes APOC, generated $8.23 billion, representing 19% of Abbott’s total revenue.

Contact Information

Address: 1000 Alere Park Drive, Johnson City, NY 13790, USA

Keywords: Abbott Point of Care Inc., point-of-care diagnostics, i-STAT® System, ID NOW™ platform, rapid diagnostic tests, POCT, Alere™ Toxicology, BinaxNOW™, Panbio™

文章下方广告位

猜你喜欢

网友评论